Literature DB >> 9188776

Human L-3-phosphoserine phosphatase: sequence, expression and evidence for a phosphoenzyme intermediate.

J F Collet1, I Gerin, M H Rider, M Veiga-da-Cunha, E Van Schaftingen.   

Abstract

We report the sequence of the cDNA encoding human L-3-phosphoserine phosphatase. The encoded polypeptide contains 225 residues and shows 30% sequence identity with the Escherichia coli enzyme. The human protein was expressed in a bacterial expression system and purified. Similar to known L-3-phosphoserine phosphatases, it catalyzed the Mg2(+)-dependent hydrolysis of L-phosphoserine and an exchange reaction between L-serine and L-phosphoserine. In addition we found that the enzyme was phosphorylated upon incubation with L-[32P]phosphoserine, which indicates that the reaction mechanism proceeds via the formation of a phosphoryl-enzyme intermediate. The sensitivity of the phosphoryl-enzyme to alkali and to hydroxylamine suggests that an aspartyl- or a glutamyl-phosphate was formed. The nucleotide sequence of the cDNA described in this article has been deposited in the EMBL data base under accession number Y10275.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9188776     DOI: 10.1016/s0014-5793(97)00438-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  16 in total

1.  Mutations affecting the development of the peripheral nervous system in Drosophila: a molecular screen for novel proteins.

Authors:  S N Prokopenko; Y He; Y Lu; H J Bellen
Journal:  Genetics       Date:  2000-12       Impact factor: 4.562

2.  Cap-domain closure enables diverse substrate recognition by the C2-type haloacid dehalogenase-like sugar phosphatase Plasmodium falciparum HAD1.

Authors:  Jooyoung Park; Ann M Guggisberg; Audrey R Odom; Niraj H Tolia
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2015-08-25

3.  BeF(3)(-) acts as a phosphate analog in proteins phosphorylated on aspartate: structure of a BeF(3)(-) complex with phosphoserine phosphatase.

Authors:  H Cho; W Wang; R Kim; H Yokota; S Damo; S H Kim; D Wemmer; S Kustu; D Yan
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

4.  Conserved sequence motifs among bacterial, eukaryotic, and archaeal phosphatases that define a new phosphohydrolase superfamily.

Authors:  M C Thaller; S Schippa; G M Rossolini
Journal:  Protein Sci       Date:  1998-07       Impact factor: 6.725

Review 5.  Markers of fitness in a successful enzyme superfamily.

Authors:  Karen N Allen; Debra Dunaway-Mariano
Journal:  Curr Opin Struct Biol       Date:  2009-11-02       Impact factor: 6.809

6.  L-3-Phosphoserine phosphatase (PSPH) regulates cutaneous squamous cell carcinoma proliferation independent of L-serine biosynthesis.

Authors:  Michael A Bachelor; Yan Lu; David M Owens
Journal:  J Dermatol Sci       Date:  2011-06-22       Impact factor: 4.563

7.  Differential gene expression in the adrenals of normal and anencephalic fetuses and studies focused on the Fras-1-related extracellular matrix protein (FREM2) gene.

Authors:  Christine W Mansfield; Bruce R Carr; Ona M Faye-Petersen; Dongquan Chen; Yewei Xing; William E Rainey; C Richard Parker
Journal:  Reprod Sci       Date:  2011-11       Impact factor: 3.060

Review 8.  Role of genetic detection in peritoneal washes with gastric carcinoma: The past, present and future.

Authors:  Hyun-Dong Chae
Journal:  World J Gastrointest Oncol       Date:  2016-03-15

9.  Identification of the Mg2+-binding site in the P-type ATPase and phosphatase members of the HAD (haloacid dehalogenase) superfamily by structural similarity to the response regulator protein CheY.

Authors:  I S Ridder; B W Dijkstra
Journal:  Biochem J       Date:  1999-04-15       Impact factor: 3.857

10.  Diversification of function in the haloacid dehalogenase enzyme superfamily: The role of the cap domain in hydrolytic phosphoruscarbon bond cleavage.

Authors:  Sushmita D Lahiri; Guofeng Zhang; Debra Dunaway-Mariano; Karen N Allen
Journal:  Bioorg Chem       Date:  2006-10-27       Impact factor: 5.275

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.